Table 1.
Laboratory data
| Variable | Reference range | Initial value on admission | Value after intervention for half a year |
| Routine blood examination | |||
| White cell count (× 109/L) | 3.5−9.5 | 8.08 | 12.43 |
| Red cell count (× 1012/L) | 4.3−5.8 | 3.55 | 4.04 |
| Hemoglobin (g/L) | 130−175 | 108 | 126 |
| Biochemical blood examination | |||
| Urea nitrogen (mmol/L) | 2.9−8.2 | 6.04 | 8.85 |
| Creatinine (μmol/L) | 59−104 | 133 | 109 |
| Glucose (mmol/L) | 3.9−6.1 | 4.99 | 4.99 |
| Sodium (mmol/L) | 137−147 | 139.8 | 139 |
| Potassium (mmol/L) | 3.5−5.3 | 3.81 | 3.90 |
| Chloride (mmol/L) | 99−101 | 104.7 | 103.90 |
| Calcium (mg/dL) | 2.2−2.65 | 2.15 | 2.37 |
| Phosphorus (mg/dL) | 0.81−1.45 | 1.25 | 0.96 |
| Albumin (g/L) | 40−55 | 32.51 | 41.75 |
| Immunological indexes | |||
| ANA | Negative | − | |
| ASO (U/mL) | 0−116 | Less than 25 | − |
| C3 (g/L) | 0.79−1.52 | 1.15 | − |
| C4 (g/L) | 0.16−0.38 | 0.339 | − |
| IgG (g/L ) | 7.51−15.6 | 9.87 | − |
| IgA (g/L) | 0.82−4.53 | 2.27 | − |
| IgM (g/L) | 0.46−3.04 | 0.685 | − |
| Anti-PR3-ANCA (RU/mL) | 0−20 | 0 | − |
| Anti-MPO-ANCA (RU/mL) | 0−20 | 0 | − |
| Kappa light chain (mg/dL) | Negative | − | |
| Lambda light chain (mg/dL) | Negative | − | |
| Anti-PLA2R antibody (RU/mL) | Less than 5 | − | |
| Anti-THSD7A antibody | Negative | − | |
| Anti-GBM antibody (RU/mL) | 0−20 | 68 | − |
| Urinalysis | |||
| Occult blood | 3+ | 2+ | |
| RBCs (per high-power field) | 0−3 | 45.09 | 10.6 |
| Protein | 2+ | 2+ | |
| 24 h urinary total protein (g/24 h) | 5.16 | 1.68 |
RBCs: Red blood cells; ANA: Antinuclear antibodies; ASO: Arteriosclerosis obliterans.